Literature DB >> 1308402

Electrocardiographic findings in acute cerebrovascular hemorrhage. A prospective study of 70 patients.

W O Arruda1, F S de Lacerda Júnior.   

Abstract

Seventy patients with hemorrhagic stroke were prospectively evaluated regarding the electrocardiographic abnormalities observed within the first 48 hours of the ictus. Group I comprised 55 patients with spontaneous cerebral hemorrhage, and group II 15 patients with subarachnoid hemorrhage. Patients taking cardiac drugs (beta blockers, calcium-channel blockers, inotropic drugs) or with severe metabolic/electrolyte disturbances were excluded. The most common ECG abnormality was a prolonged Q-Tc interval: group I, 37 (67.2%); group II, 8 (53.3%). Only 4 (7.2% patients of group I and no patient of group II had a normal ECG. No relation was found between the site of the intracerebral hematoma and the occurrence of any particular ECG change. A prolonged Q-Tc may be related to the development of severe cardiac arrhythmias observed in some patients with acute cerebral hemorrhage.

Entities:  

Mesh:

Year:  1992        PMID: 1308402     DOI: 10.1590/s0004-282x1992000300002

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage.

Authors:  Kohei Hasegawa; Megan L Fix; Lauren Wendell; Kristin Schwab; Hakan Ay; Eric E Smith; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein; David F M Brown
Journal:  Am J Emerg Med       Date:  2011-03-29       Impact factor: 2.469

2.  ECG Changes in Subarachnoid Haemorrhage: A Synopsis.

Authors:  S Chatterjee
Journal:  Neth Heart J       Date:  2011-01       Impact factor: 2.380

3.  Prevalence and characterization of ECG abnormalities after intracerebral hemorrhage.

Authors:  Maurits D R van Bree; Yvo B W E M Roos; Ivo A C van der Bilt; Arthur A M Wilde; Marieke E S Sprengers; Koen de Gans; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.